IP Library Patent Application 18765089
Patent Application
App. No. 18/765,089

COMPOSITIONS AND METHODS FOR INHIBITING FACTOR D

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
18/765,089
Abstract

The application discloses methods and compositions for the inhibition of the alternative complement pathway. The methods and compositions involve the use of aptamers for inhibiting complement Factor D. The application further provides anti-Factor D aptamers for the treatment of dry age-related macular degeneration, geographic atrophy, wet age-related macular degeneration or Stargardt disease.

Claims (5)

1 - 66 . (canceled)

67 . An aptamer that selectively binds to a self-inhibitory loop of complement Factor D.

68 . An aptamer that selectively binds to an exosite of complement Factor D.

69 . A method of treating a subject having a disease or disorder, the method comprising administering to the subject the aptamer of claim 67 , thereby treating the subject.

70 . The method of claim 69 , wherein the disease or disorder is an ocular disease or disorder.

Assignments (4)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 8, 2024
From: VITRISA THERAPEUTICS, INC.
To: 396419 B.C. LTD.
Reel/Frame 067929/0866 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 8, 2024
From: 396419 B.C. LTD.
To: CALW INVESTMENT CO. INC.
Reel/Frame 067929/0901 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 8, 2024
From: 396419 B.C. LTD.; CALW INVESTMENT CO. INC.
To: OAK BAY BIOSCIENCES INC.
Reel/Frame 067930/0113 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 8, 2024
From: ERICKSON, CARL; RUSCONI, CHRISTOPHER P.; MCLURE, KEVIN G.
To: VITRISA THERAPEUTICS, INC.
Reel/Frame 068219/0520 →